By Alberto Alerigi SAO PAULO (Reuters) -Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide ...

A study by Mass General Brigham found that taking the weight-loss drug semaglutide before bariatric surgery does not lead to better overall weight loss outcomes. The research suggests that ...

On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 (GLP-1) medication, marking the shortage as ...

Ozempic (semaglutide) is a prescription drug used for certain conditions in people with type 2 diabetes. Ozempic is given as an injection under your skin. Ozempic can be prescribed for adults with ...

Eli Lilly lowered Zepbound’s starter dose to $349 per month The lower prices are available for uninsured patients and folks whose insurance doesn't cover the drugs ...

But it also underscores the pressure that women in the public eye are under, and brings me to question what lengths they are being asked to go to in order to retain their box-office value or ...

The Post talked to three people taking semaglutide, plus one weight loss doctor, to find out what’s motivating them to stay mum. Jennifer*, a 50-something from New Jersey, has lost 40 lbs.

Drug com­pounders have sued the FDA to put the weight loss and di­a­betes drug semaglu­tide back on an of­fi­cial short­age list, fight­ing a reg­u­la­to­ry de­ci­sion … ...

Compounders have been permitted to manufacture copycat versions of Novo’s semaglutide and Lilly’s tirzepatide since 2022 when the FDA declared that both were in shortage. In October ...

This legal move, initiated by the Outsourcing Facilities Association and others in a Fort Worth, Texas federal court, argues that the FDA's ruling, which states no existing shortage of the active ...

Makers of copycat versions of Novo Nordisk's (NVO) popular weight-loss drug semaglutide, also known as Ozempic and Wegovy, are suing the FDA for removing the GLP-1 medication from its shortage list.